Cargando…
An LC-MS/MS Bioanalytical Assay for the Determination of Gilteritinib in Rat Plasma and Application to a Drug–Drug Interaction Study
BACKGROUND: Gilteritinib, a novel, potent FLT3/AXL inhibitor, was recently approved in Japan and USA for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation. PURPOSE AND METHODS: In this study, we aimed to develop and validate a sensitive...
Autores principales: | Wang, Qiong, Chen, Zhe, Chen, Dingwen, Ye, Xia-yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266109/ https://www.ncbi.nlm.nih.gov/pubmed/32546970 http://dx.doi.org/10.2147/DDDT.S243760 |
Ejemplares similares
-
TROUBLE SHOOTING DURING BIOANALYTICAL ESTIMATION OF DRUG AND METABOLITES USING LC-MS/MS: A REVIEW
por: Sharma, Ganesh N., et al.
Publicado: (2010) -
Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application
por: Dhanure, Shivanand, et al.
Publicado: (2014) -
Bioanalytical method development and validation of milnacipran in rat plasma by LC–MS/MS detection and its application to a pharmacokinetic study
por: Kanala, Kanchanamala, et al.
Publicado: (2013) -
Bioanalytical method development and validation of alimemazine in human plasma by LC-MS/MS and its application in bioequivalence studies
por: Singh, Bhupinder, et al.
Publicado: (2013) -
Determination of Scopolamine Distribution in Plasma and Brain by LC-MS/MS in Rats
por: Chen, Juan, et al.
Publicado: (2022)